Efficacy of convalescent plasma for treatment of COVID-19 in Uganda.
Bruce J KirengaPauline Byakika-KibwikaWinters MuttambaAlex KayongoNamakula Olive LoryndahLevicatus MugenyiNoah KiwanukaJohn LusibaAngella AtukundaRaymond MugumeFrancis SsaliHenry DdunguWinceslaus KatagiraRogers SekibiraCissy KityoDorothy KyeyuneSusan AcanaHellen Aanyu-TukamuhebwaWilberforce KabweruFred NakwagalaBernard Sentalo BagayaIvan KimuliRebecca NantandaEsther BuregyeyaBaterana ByarugabaCharles OlaroHenry MwebesaMoses Lutaakome JolobaTrishul SiddharthanWilliam BazeyoPublished in: BMJ open respiratory research (2021)
In this African trial, CCP therapy did not result in beneficial virological or clinical improvements. Further trials are needed to determine subgroups of patients who may benefit from CCP in Africa.Trial registration number NCT04542941.